Jeanne Tie

Cancer Treatment Patterns and Factors Affecting Receipt of Treatment in Older Adults: Results from the ASPREE Cancer Treatment Substudy (ACTS).

Jaidyn Muhandiramge, Erica T Warner, John R Zalcberg, Andrew Haydon, Galina Polekhina, Gijsberta J van Londen, Peter Gibbs, Wendy B Bernstein, Jeanne Tie, Jeremy L Millar, Victoria J Mar, John J McNeil, Robyn L Woods, Suzanne G Orchard, undefined ASPREE Investigator Group

Journal article  |  2023  |  Cancers (Basel)

INTRODUCTION: Cancer treatment planning in older adults is complex and requires careful balancing of survival, quality of life ben..

BREAKWATER safety lead-in (SLI): Encorafenib (E) cetuximab (C) chemotherapy for BRAFV600E metastatic colorectal cancer (mCRC).

Scott Kopetz, Takayuki Yoshino, Tae Won Kim, Rona Yaeger, Jayesh Desai, Harpreet Singh Wasan, Eric Van Cutsem, Fortunato Ciardiello, Tim Maughan, Cathy Eng, Jeanne Tie, Elena Elez, Sara Lonardi, Xiaosong Zhang, Chin-Hee Chung, Tiziana Usari, Tim Nicholz, Danielle A Murphy, Josep Tabernero

Journal article  |  2023  |  Journal of Clinical Oncology

119 Background: Based on the phase 3 BEACON study (NCT02928224), BRAF inhibitor (i) encorafenib (E) + EGFRi cetuximab (C) was app..

Comprehensive characterization of KRAS mutations and inter-relation with primary tumor location in colorectal cancers.

Mohamed E Salem, Scott Kopetz, Josep Tabernero, Frank A Sinicrope, Myriam Chalabi, Jeanne Tie, Kunal C Kadakia, Thomas J George, Elizabeth Mauer, Lisa Macera, Calvin Y Chao, Sara Lonardi, Eric Van Cutsem, Thierry Andre, Michael J Overman

Journal article  |  2023  |  Journal of Clinical Oncology

231 Background: The recent development of KRAS G12C inhibitors underscores the potential to target KRAS mutations. Right-sided an..

Low intensity treatment in metastatic colorectal cancer.

Hui-Li Wong, Jeanne Tie

Journal article  |  2023  |  Lancet Gastroenterol Hepatol

Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review

Yat Hang To, Peter Gibbs, Jeanne Tie, Maarten IJzerman, Koen Degeling

Journal article  |  2023  |  COST EFFECTIVENESS AND RESOURCE ALLOCATION

OBJECTIVE: The aims of this study was to appraise the health economic evidence for adjuvant chemotherapy (AC) strategies in stage ..

Phase Ib/II Trial of BRAF and EGFR inhibition in BRAFV600E metastatic colorectal cancer and other cancers: EVICT (Erlotinib and Vemurafenib In Combination Trial).

Lavinia Tan, Ben Tran, Jeanne Tie, Ben Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David Ritchie, Rachel Koldej, Benjamin J Solomon, Grant A McArthur, Rodney J Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai

Journal article  |  2023  |  Clin Cancer Res

PURPOSE: BRAF V600E mutant metastatic colorectal cancer represents a significant clinical problem, with combination approaches bei..

Real-world adjuvant chemotherapy treatment patterns and outcomes over time for resected stage II and III colorectal cancer

Yat Hang To, Koen Degeling, Melanie McCoy, Rachel Wong, Ian Jones, Catherine Dunn, Wei Hong, Matthew Loft, Peter Gibbs, Jeanne Tie

Journal article  |  2022  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

BACKGROUND: The administration of adjuvant chemotherapy (AC) to colorectal cancer (CRC) patients in Australia and impact of recent..

160P COLUMBIA-1: A phase Ib/II, open-label, randomized, multicenter study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab as first-line (1L) therapy in metastatic microsatellite-stable colorectal cancer (MSS-mCRC)

NH Segal, J Tie, S Kopetz, MP Ducreux, E Chen, R Dienstmann, A Hollebecque, M Reilley, ME Elez Fernandez, J Cosaert, J Cain, M Hernandez, N Hewson, ZA Cooper, M Dressman, J Tabernero

Journal article  |  2022  |  Immuno-Oncology and Technology

Pharmacogenetic testing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1) based chemotherapies in routine clinical care: Perspectives of medical oncologists and oncology pharmacists

Sarah Glewis, Senthil Lingaratnam, Mei Krishnasamy, Jennifer Martin, Jeanne Tie, Marliese Alexander, Michael Michael

Conference Proceedings  |  2022  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

The impact of molecular and mismatch repair status on the survival outcomes of surgically treated patients with colorectal peritoneal metastases

Michael P Flood, Anshini Jain, Catherine Mitchell, Chelsee Hewitt, Robert Ramsay, Michael Michael, Alexander G Heriot, Jeanne Tie

Journal article  |  2022  |  EJSO

BACKGROUND: Stratification of patients with colorectal peritoneal metastases (CRPM) using RAS/BRAF mutational status may refine pa..